Legend Biotech Corporation
LEGN
$34.86
$1.374.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -250.18M | -296.88M | -239.76M | -325.39M | -218.21M |
| Total Depreciation and Amortization | 39.30M | 28.80M | 23.24M | 21.26M | 20.78M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 224.15M | 261.55M | 152.15M | 217.94M | 83.96M |
| Change in Net Operating Assets | -94.81M | -93.51M | -105.51M | -188.32M | -149.65M |
| Cash from Operations | -81.55M | -100.05M | -169.89M | -274.51M | -263.12M |
| Capital Expenditure | -34.10M | -28.60M | -18.60M | -15.66M | -9.86M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 319.06M | 738.16M | 1.78M | 347.92M | -188.00M |
| Cash from Investing | 284.96M | 709.56M | -16.82M | 332.25M | -197.85M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.12M | -3.62M | -3.58M | -4.15M | -4.04M |
| Issuance of Common Stock | 1.96M | 3.26M | 3.53M | 7.67M | 9.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.17M | -367.00K | -51.00K | 3.52M | 5.47M |
| Foreign Exchange rate Adjustments | 3.50M | 6.10M | 6.39M | 4.08M | -357.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 204.75M | 615.25M | -180.37M | 65.34M | -455.86M |